A CASE OF NONNEUROLOGIC GAUCHERS-DISEASE THAT BIOCHEMICALLY RESEMBLES THE NEUROLOGIC TYPES

被引:13
作者
GLEW, RH
GOPALAN, V
HUBBELL, CA
BEUTLER, E
GEIL, JD
LEE, RE
机构
[1] UNIV NEW MEXICO, SCH MED, ALBUQUERQUE, NM 87131 USA
[2] SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA
[3] UNIV KENTUCKY, COLL MED, DEPT PEDIAT, LEXINGTON, KY 40506 USA
[4] UNIV PITTSBURGH, SCH MED, DEPT PATHOL, PITTSBURGH, PA 15261 USA
关键词
GAUCHERS DISEASE; MUTATION GENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION ENDONUCLEASE ANALYSIS;
D O I
10.1097/00005072-199103000-00002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Systemic findings such as hepatosplenomegaly and typical Gaucher storage cells in a bone marrow aspirate led to the clinical diagnosis of Gaucher's disease in the seven-year old patient described in this report. On the basis of the lack of neurologic involvement the child was classified as having the Type 1, nonneurologic form of Gaucher's disease. After splenectomy glucocerebrosidase was extracted from her spleen for biochemical analysis. As expected, a marked deficiency of glucocerebrosidase activity was evident in the splenic extract, however her enzyme displayed anomalous behavior compared to other identical splenic preparations from documented Type 1 Gaucher's disease patients in that it failed to reconstitute with the acidic lipid phosphatidylserine. Using the polymerase chain reaction (PCR)-based color complementation assay and restriction endonuclease analysis, we compared the mutation genotype of this child with that of five other classical Type 1 patients. This analysis revealed that our patient alone was homoallelic for a T --> C transition at position 1448 in the glucocerebrosidase cDNA that results in a 444Leu --> Pro substitution in the glucocerebrosidase protein. The latter mutation genotype is normally associated with the neurologic phenotype, namely, the Types 2 and 3 forms of the disease. The relevance of the nature of polarity in clinical and biochemical analyses is discussed with regard to the phenotypic classification and the future clinical course of disease in the child.
引用
收藏
页码:108 / 117
页数:10
相关论文
共 25 条
[1]   METABOLISM OF GLUCOCEREBROSIDES .2. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHERS DISEASE [J].
BRADY, RO ;
KANFER, JN ;
SHAPIRO, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1965, 18 (02) :221-&
[2]  
BUETLER E, 1990, ANN HUM GENET, V54, P149
[3]   DETECTION OF SPECIFIC DNA-SEQUENCES BY FLUORESCENCE AMPLIFICATION - A COLOR COMPLEMENTATION ASSAY [J].
CHEHAB, FF ;
KAN, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9178-9182
[4]   ENZYME REPLACEMENT THERAPY IN GAUCHERS-DISEASE - LARGE-SCALE PURIFICATION OF GLUCOCEREBROSIDASE SUITABLE FOR HUMAN ADMINISTRATION [J].
FURBISH, FS ;
BLAIR, HE ;
SHILOACH, J ;
PENTCHEV, PG ;
BRADY, RO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (08) :3560-3563
[5]   DETERMINATION OF GAUCHERS-DISEASE PHENOTYPES WITH MONOCLONAL-ANTIBODY [J].
GINNS, EI ;
TEGELAERS, FPW ;
BARNEVELD, R ;
GALJAARD, H ;
REUSER, AJJ ;
BRADY, RO ;
TAGER, JM ;
BARRANGER, JA .
CLINICA CHIMICA ACTA, 1983, 131 (03) :283-287
[6]   ENZYMIC DIFFERENTIATION OF NEUROLOGIC AND NON-NEUROLOGIC FORMS OF GAUCHERS-DISEASE [J].
GLEW, RH ;
DANIELS, LB ;
CLARK, LS ;
HOYER, SW .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1982, 41 (06) :630-641
[7]  
GLEW RH, 1988, LAB INVEST, V58, P5
[8]   GAUCHER DISEASE TYPE-1 - CLONING AND CHARACTERIZATION OF A CDNA-ENCODING ACID BETA-GLUCOSIDASE FROM AN ASHKENAZI JEWISH PATIENT [J].
GRAVES, PN ;
GRABOWSKI, GA ;
EISNER, R ;
PALESE, P ;
SMITH, FI .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1988, 7 (08) :521-528
[9]   THE HUMAN GLUCOCEREBROSIDASE GENE AND PSEUDOGENE - STRUCTURE AND EVOLUTION [J].
HOROWITZ, M ;
WILDER, S ;
HOROWITZ, Z ;
REINER, O ;
GELBART, T ;
BEUTLER, E .
GENOMICS, 1989, 4 (01) :87-96
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265